Home Link Logo
Login

Sysmex Corporation has acquired the shares of Hyphen BioMed SAS

Sysmex Corporation has acquired the shares of Hyphen BioMed SAS

  • Deal Stage:  closed transaction
  • Service:  sell
  • Sector: Healthcare
  • Sub-sector:
  • Contact Email: aodin@ddacompany.com

Description

DDA & Company represented the shareholders of Hyphen BioMed SAS, a scientific company boasting an extended experience in the field of Thrombosis, Haemostasis and Auto-Immunity providing a comprehensive offering of diagnostic and research reagents, distributed worldwide, on its sale to Japanese listed Sysmex Corporation

Members of this Deal

Select Member
Alexandre Odin
EMEA
View Profile

Other Deals by DDA & Company

Select Deal
Select Deal
Select Deal
Select Deal
View Deals

More Deals in the Healthcare sector

Select Deal
Select Deal
Select Deal
Select Deal
View Deals